Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy.

Autor:	Jiménez-Galán R; Department of pharmacy. Valme university Hospital, Seville.. rociojg85@hotmail.com., Cantudo Cuenca MR; Department of pharmacy. Valme university Hospital, Seville.. rociojg85@hotmail.com., Robustillo-Cortés MA; Department of pharmacy. Valme university Hospital, Seville.. rociojg85@hotmail.com., Borrego Izquierdo Y; Department of pharmacy. Valme university Hospital, Seville.. rociojg85@hotmail.com., Almeida-Gonzalez CV; Research Unit. Valme university Hospital, Seville. Spain.. rociojg85@hotmail.com., Morillo-Verdugo R; Department of pharmacy. Valme university Hospital, Seville.. rociojg85@hotmail.com.
Jazyk:	angličtina
Zdroj:	Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2016 Jun 01; Vol. 40 (4), pp. 272-8. Date of Electronic Publication: 2016 Jun 01.
DOI:	10.7399/fh.2016.40.4.10453
Abstrakt:	Background: Decreased antiretroviral therapy persistence is associated with increased rates of virologic failure, development of antiretroviral resistance, and increased morbidity and mortality. Different therapeutic strategies, such as single-tablet regimens (STR) and less-drug regimens (LDR), have been developed in order to simplify antiretroviral therapy (ART) and increase persistence. Objectives: The primary objective was to compare antiretroviral persistence among patients receiving STRs and patients receiving LDRs. A secondary objective was to identify factors associated with non-persistence. Methods: This was a retrospective study that included treatment- experienced HIV-infected patients who received ART based on STR or LDR. Baseline patient characteristics collected included demographic information, HIV risk transmission, substance abuse during the therapy, presence of psychiatric disorder and hepatitis B or C virus infection. Kaplan-Meier analysis and Log rank was utilized to compare persistence to STR and LDR. To identify independent predictors of non-persistence we developed a multivariate Cox regression analysis. Results: A total of 244 patients were included, 176 with STR and 68 with LDR. 60 (34.1%) patients discontinued in the STR group and 13 (19.1%) in the LDR group. The Cox regression model showed that the only variable associated with higher risk of non-persistence was the substance abuse (HR = 2.59; p = 0.005). Adverse events were the main reason for ART discontinuation in the STR group and virologic failure in the LDR group. Conclusions: Persistence to STR and LDR seems to be similar in pretreated HIV-infected patients. Drug abuse was the only factor identified with a higher risk of non-persistence. (Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu